Why the Painchek (ASX:PCK) share price is charging 13% higher
Mitchell Lawler | March 17, 2021 12:51pm |
More on:
The
PainChek Ltd(ASX: PCK) share price is soaring today after the company announced it has received approvals for its latest pain monitoring app update.
At the time of writing, the mobile medical app developer’s shares are up 13% to 7.8 cents per share.
What did Painchek announce?
The Painchek share price is moving after it provided an update this morning noting the company had received CE Mark and Therapeutic Goods Administration (TGA) clearance for its expanded Universal Pain Assessment Solution, or ‘Universal’ application.
According to the release, these clearances will allow the app to be marketed and sold across Europe, the UK, Australia, Canada, Singapore, and New Zealand.